Trade Tectonic Therapeutic Inc - TECX
Tectonic Therapeutic Inc (NASDAQ: TECT) is a biotechnology company developing novel GPCR-targeted therapies for rare and chronic diseases. Using structure-based drug design and proprietary platform technology, it aims to unlock previously undruggable receptors. Tectonic’s shares move with clinical milestones, licensing partnerships, and progress advancing its pipeline of precision therapeutics.Latest shares articles

Rocket Lab stock forecast: Iridium acquisition equity funding
Rocket Lab is a US space company listed on Nasdaq. On 15 September, it completed a $1.944bn equity offering to fund its pending acquisition of Iridium Communications. Explore third-party RKLB price targets. Past performance is not a reliable indicator of future results.
9 hours ago

Bitfarms stock forecast: $819m liquidity, no tenant yet
Keel Infrastructure became Bitfarms’ parent company in April 2026, with the group shifting towards data-centre development. Explore third-party KEEL price targets and technical analysis. Past performance is not a reliable indicator of future results.
11 hours ago

Air Liquide stock forecast: Elliott stake, hydrogen initiative
Air Liquide is a French industrial gases group. Reuters reported that Elliott Investment Management built a stake, while Air Liquide joined a European hydrogen mobility initiative. Explore third-party AI price targets. Past performance is not a reliable indicator of future results.
11 hours ago

Allianz stock forecast: record H1 profit, Q3 earnings ahead
Allianz is a German insurer whose shares are trading near record levels following record first-half operating profit and reports of a possible €5.8 billion acquisition of AA. Explore third-party ALV targets and technicals. Past performance is not a reliable indicator of future results.
13:26, 30 September 2026
Related News
Public Technologies